Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomised, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone
Davies, J S
Scanlon, M F
American Journal of Human Biology
MetadataShow full item record
This paper evaluates the effects and safety of replacement recombinant human growth hormone (rhGH) on measures of body composition, bone mineral, and biochemical and clinical cardiovascular risk factors in growth hormone deficient adults. The study was randomised, double-blind and placebo controlled. In general, administration of rhGH was well tolerated. Somatic, body composition and cardiovascular risk factors responded favourably to treatment, which have implications for further health research in growth hormone deficiency. Bell contributed to data collection/analysis and wrote the manuscript.
16 (5), pp.533-543
- Sport Research Groups 
Showing items related by title, author, subject and abstract.
The effect of differing sources of fetal calf serum on the growth and proliferation of HEK293T cells Player, Tim (Cardiff Metropolitan University, 2011)Fetal calf serum (FCS) is often used in cell culture to supply the cells with growth factors, hormones, attachment factors, nutrients and many other substances they require for growth and proliferation. However, variability ...
Graham, M. R; Gu, Y; Evans, P. J.; Cooper, Stephen-Mark; Davies, B; Baker, J.S. (AI Publications, 2017-07-01)Objectives: In arterial hypertension, amino-terminal propeptide of type III procollagen (PIIINP) is elevated in arterial aneurysm tissue and associated with a poor prognosis following acute myocardial infarction (MI). ...
Al Shuraiqi, Rajaa (Cardiff Metropolitan University, 2011)Hepcidin a hepatic peptide hormone mainly produces by the liver tissue, it is also produce in a small amount by other tissue including lung, heart and macrophages. Hepcidin plays a critical role in iron regulation and ...